A Lacoma
Overview
Explore the profile of A Lacoma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacoma A, Cano V, Moranta D, Regueiro V, Dominguez-Villanueva D, Laabei M, et al.
Virulence
. 2017 Aug;
8(8):1761-1775.
PMID: 28762868
Objective: Staphylococcus aureus is a particularly difficult pathogen to eradicate from the respiratory tract. Previous studies have highlighted the intracellular capacity of S.aureus in several phagocytic and non-phagocytic cells. The...
2.
Molina-Moya B, Lacoma A, Garcia-Sierra N, Blanco S, Haba L, Samper S, et al.
Sci Rep
. 2017 Jul;
7(1):6777.
PMID: 28754991
We developed a novel method, PyroTyping, for discrimination of Mycobacterium tuberculosis isolates combining pyrosequencing and IS6110 polymorphism. A total of 100 isolates were analysed with IS6110-restriction fragment length polymorphism (RFLP),...
3.
Molina-Moya B, Kazdaglis G, Lacoma A, Prat C, Gomez A, Villar-Hernandez R, et al.
J Clin Microbiol
. 2016 Jul;
54(8):2211.
PMID: 27458275
No abstract available.
4.
Molina-Moya B, Kazdaglis G, Lacoma A, Prat C, Gomez A, Villar-Hernandez R, et al.
J Clin Microbiol
. 2016 Feb;
54(4):1160-3.
PMID: 26865688
The aim of this study was to evaluate the GenoFlow DR-MTB array test (DiagCor Bioscience, Hong Kong) on 70 cultured isolates and 50 sputum specimens. The GenoFlow array test showed...
5.
Molina-Moya B, Lacoma A, Prat C, Pimkina E, Diaz J, Garcia-Sierra N, et al.
J Infect
. 2015 May;
71(2):220-30.
PMID: 25936742
Objective: To study the diagnostic accuracy of a multiplex real-time PCR (Anyplex II MTB/MDR/XDR, Seegene, Corea) that detects Mycobacterium tuberculosis resistant to isoniazid (INH), rifampicin (RIF), fluoroquinolones (FLQ) and injectable...
6.
Molina-Moya B, Lacoma A, Prat C, Diaz J, Dudnyk A, Haba L, et al.
J Infect
. 2014 Oct;
70(4):400-8.
PMID: 25305498
Objectives: To determine the sensitivity and specificity of AID TB Resistance line probe assay (AID Diagnostika, Germany) to detect Mycobacterium tuberculosis and its resistance to first- and second-line drugs in...
7.
Lacoma A, Garcia-Sierra N, Prat C, Maldonado J, Ruiz-Manzano J, Haba L, et al.
J Clin Microbiol
. 2011 Nov;
50(1):30-6.
PMID: 22075597
The purpose of this study was to evaluate the GenoType MTBDRsl assay (Hain Lifescience GmbH, Nehren, Germany) for its ability to detect resistance to fluoroquinolones (FLQ), injectable second-line antibiotics [kanamycin...
8.
Lacoma A, Rodriguez N, Prat C, Ruiz-Manzano J, Andreo F, Ramirez A, et al.
Eur J Clin Microbiol Infect Dis
. 2011 Aug;
31(5):825-33.
PMID: 21870054
The aim of this study was to investigate whether procalcitonin (PCT), neopterin, C-reactive protein (CRP), and mid regional pro-atrial natriuretic peptide (MR-proANP) levels at admission and during the clinical course...
9.
Garcia-Sierra N, Lacoma A, Prat C, Haba L, Maldonado J, Ruiz-Manzano J, et al.
J Clin Microbiol
. 2011 Aug;
49(10):3683-6.
PMID: 21813715
The aim of this study was to evaluate a pyrosequencing method for the detection of Mycobacterium tuberculosis isolates resistant to rifampin and isoniazid using both clinical strains and clinical samples,...
10.
Lacoma A, Prat C, Andreo F, Dominguez J
Eur Respir Rev
. 2010 Oct;
18(112):96-104.
PMID: 20956129
Chronic obstructive pulmonary disease (COPD) is still a leading cause of morbidity and mortality worldwide, with a huge socioeconomic impact. New strategies for the management of COPD are required, not...